At the second annual Tufts Women's Health Summit, held on the university's Boston health sciences campus, faculty and researchers from across the institution delivered a consistent message: women's health remains understudied and underfunded, and the medical research establishment has only begun to reckon with the fact that female bodies differ from male bodies in ways that matter across every organ system.
“Women’s health is at an inflection point,” said Helen Boucher, dean of Tufts University School of Medicine and chief academic officer for Tufts Medicine, according to a Tufts Now report on the summit. “For too long, this area has been understudied, underfunded, and viewed through way too narrow a lens.”
The summit drew researchers, physicians, faculty, and students for a day of panel discussions and networking. The keynote address was delivered by Kalahn A. Taylor-Clark, vice president and head of social impact and sustainability at Merck and a member of the Tufts University Board of Trustees.
The event was co-led by Jamie Maguire, the Kenneth and JoAnn G. Wellner Professor of Neuroscience and vice dean for research at the School of Medicine, and Perrie O’Tierney-Ginn, professor of obstetrics and gynecology and executive director of the Woman, Mother + Baby Research Institute at Tufts Medical Center. They highlighted the establishment of several multidisciplinary translational research groups (MTRGs) under the women's health, nutrition, and sex differences pillar of the Tufts University-Tufts Medicine Research Enterprise. These groups focus on cardiometabolic health across the lifespan, breast cancer, HPV, chronic diseases of aging, menopause, perinatal and intergenerational health, and women's mental health.
Women's health is not a niche issue
Taylor-Clark argued in her keynote that women's health should not be treated as a separate or specialized category. “It's a lens for understanding how sex, gender, biology, environment, and systems shape the health of all of us,” she said, as reported by Tufts Now. She emphasized that the field should encompass not only conditions unique to female biology, like pregnancy and menopause, but also conditions that disproportionately affect women, such as Alzheimer's disease, cardiovascular disease, and other chronic illnesses where women may experience different risks, symptoms, outcomes, or gaps in care.
She also stressed that improving women's health requires collaboration across sectors and communities, including researchers, healthcare providers, industry, governments, employers, community organizations, and patients. “If we want better outcomes for women, we need to broaden both whom we study and whom we engage in creating solutions,” she said.
Menopause as a whole-body transition
A panel on menopause and midlife health, moderated by Larissa Calancie, the Linda and Jeffrey Moslow Assistant Professor of Women’s Health and Menopause at the Friedman School of Nutrition Science and Policy, emphasized that menopause affects far more than hot flashes and that symptoms can begin years before periods stop.
Perimenopause can bring sleep disruption, weight redistribution, joint pain, mood changes, and brain fog, said Megan Evans, the Linda and Jeffrey Moslow Associate Professor in Women’s Health and Menopause at the School of Medicine and clinical director of the Women’s Health + Longevity Program at Tufts Medical Center. “A lot of patients will go to multiple doctors—a mental health specialist, their primary care doctor, an orthopedic surgeon for their joint pain—and it's very siloed care,” Evans said, according to Tufts Now.
Heart health in midlife
A major theme of the discussion was that women's risk of cardiovascular disease increases during and after menopause. Lower estrogen levels can affect cholesterol, blood vessels, inflammation, and body fat distribution. Ayan Patel, professor of medicine at the School of Medicine and director of the Women’s Heart Center at Tufts Medical Center, said managing cardiovascular risk factors—hypertension, high cholesterol, smoking, diabetes, diet, and weight—is the first step. “A multidisciplinary medical team really can be helpful for this particular patient group where the symptoms and effects can be so myriad,” Patel said.
Systems matter more than individual choices
A panel on women's cardiometabolic health and nutrition, moderated by Erin Hennessy, associate professor and dean for research strategy at the Friedman School, stressed that while individual choices matter, they occur within broader social and economic realities. Food access, poverty, caregiving demands, work schedules, and public policy all play a role.
Katie Stebbins, executive director of the Food & Nutrition Innovation Institute at the Friedman School, expressed frustration at the slow pace of systemic change. “I keep asking, ‘What amount of data are we going to need to finally create upstream changes?’” Stebbins said, as reported by Tufts Now. “How can I finally prove that we need to change as a society, that the economy we have built is not built for us? It doesn't support us. It's making us sicker.”
GLP-1 medications are not a complete solution
GLP-1 medications were described as transformative for obesity treatment, but speakers cautioned that they are not a complete solution. Long-term success still depends on healthy eating, physical activity, maintaining muscle mass, habit change, and ongoing support. Erin Mauney, assistant professor at the School of Medicine and a pediatric gastroenterologist, said she prescribes these medications because pediatric obesity remains a massive epidemic, but emphasized the need for prevention strategies that address the root causes of obesity and cardiometabolic disease.
For university students, the summit's message is relevant beyond medical and public health fields. The persistent underfunding and narrow framing of women's health research affects the quality of care that half the population will receive across their lifetimes. Students studying medicine, nutrition, public policy, or any field that touches human health may find that the gaps identified at the summit—in research, clinical practice, and systemic support—represent both a critique of the current system and a call to action for the next generation of researchers and practitioners.